dMMR Colorectal Cancer

Explore clinical trials studying dMMR Colorectal Cancer. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

dMMR Colorectal Cancer trial results

Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions: Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations: Mercy Hospital - FTS Fort Smith, Arkansas, United States

Frederick Health Hospital Frederick, Maryland, United States

Mercy Hospital - SPG Springfield, Missouri, United States

Mercy Hospital - South St Louis, Missouri, United States

View Trial Details

Recruiting

Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers

NCT05239546

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +10 more
Locations: University of Iowa Hospitals & Clinics Iowa City, Iowa, United States

University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Recruiting

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

NCT06613165

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Xijing hospital Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07689812

Conditions: Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer

NCT07409844

Conditions: Colon Cancer Stage I, Colon Cancer Stage II/III, Colonic Diseases, +13 more
Locations: Zealand University Hospital Køge, Denmark

View Trial Details

Completed

Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy

NCT06414304

Conditions: Cancer, Colon Adenocarcinoma, Colonic Diseases, +19 more
Locations: N.N.Blokhin National Medical Research Center of Oncology Moscow, Russia

State Budgetary Institution of Healthcare of the City of Moscow "Moscow Multidisciplinary Clinical Center "Kommunarka" of the Department of Health of the City of Moscow Moscow, Russia

View Trial Details

Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions: Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations: CARTI Cancer Center Little Rock, Arkansas, United States

Salinas Valley Memorial Healthcare System Salinas, California, United States

AdventHealth Orlando Orlando, Florida, United States

Memorial Health System Pembroke Pines, Florida, United States

View Trial Details

dMMR Colorectal Cancer

dMMR Colorectal Cancer trial results

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer

Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

Related conditions